Immediate Impact
1 by Nobel laureates 52 standout
Citing Papers
Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
2024 Standout
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Works of Atsuto Mouri being referenced
Effectiveness of EGFR‐TKI rechallenge immediately after PD ‐1 blockade failure
2021
Clinical difference between discontinuation and retreatment with nivolumab after immune-related adverse events in patients with lung cancer
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Atsuto Mouri | 496 | 366 | 54 | 86 | 70 | 637 | |
| Fumihiko Kinoshita | 298 | 234 | 36 | 79 | 60 | 522 | |
| Pernelle Lavaud | 361 | 275 | 23 | 75 | 68 | 518 | |
| Yu Miura | 548 | 367 | 26 | 171 | 45 | 719 | |
| Yosuke Kawashima | 589 | 326 | 73 | 111 | 40 | 698 | |
| Hüseyin Mertsoylu | 312 | 203 | 57 | 48 | 61 | 530 | |
| Nuria Kotecki | 315 | 276 | 48 | 95 | 66 | 567 | |
| Naoko Morishita | 250 | 387 | 34 | 36 | 61 | 557 | |
| Shinsuke Saisho | 401 | 315 | 29 | 157 | 46 | 707 | |
| Taiji Kuwata | 316 | 356 | 28 | 59 | 72 | 617 | |
| Guang Li | 394 | 368 | 76 | 109 | 57 | 728 |
All Works
Login with ORCID to disown or claim papers
Loading papers...